HKU COVID-19 vaccine trials to start in July
Share - WeChat

A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- China launches first national standard on school meal services
- China's nano 'two-photon factory' sets world record
- Low-altitude transit route links Shanghai, Jiangsu
- Shanghai-Hong Kong Youth Choir Festival launches
- Chinese courts step up efforts to safeguard stability
- Former tech group executive sentenced for bribery